Literature DB >> 6317378

NADH oxidation in submitochondrial particles protects respiratory chain activity against damage by adriamycin-Fe3+.

E J Demant.   

Abstract

Oxidative decomposition of polyunsaturated fatty acid moieties of membrane lipid in pig heart submitochondrial particles, as initiated by ferric ion complexes of the antineoplastic drug adriamycin and concomitant inactivation of oxidase activities, is counteracted by EDTA, low oxygen pressure, a phenolic antioxidant and NADH oxidation through the respiratory chain but not by scavengers of reactive oxygen species. Protection by NADH is strengthened by removal of cytochrome c from the submitochondrial particles and by antimycin A but abolished by rotenone. Inhibition of cytochrome c oxidase activity by the adriamycin-Fe3+ complex is reversible and activity is recovered upon cholate solubilization of the particles. ADP inhibits binding of the complex to the submitochondrial particles and protects both cytochrome c oxidase activity and membrane lipid. The results are discussed in relation to the possible role of mitochondrial function in protection against free-radical-mediated effects of adriamycin.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317378     DOI: 10.1111/j.1432-1033.1983.tb07803.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Oxidative and non-oxidative mechanisms in the inactivation of cardiac mitochondrial electron transport chain components by doxorubicin.

Authors:  O Marcillat; Y Zhang; K J Davies
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

Review 2.  Functional binding of cardiolipin to cytochrome c oxidase.

Authors:  N C Robinson
Journal:  J Bioenerg Biomembr       Date:  1993-04       Impact factor: 2.945

3.  Transmembrane distribution of lipophilic cations in response to an electrochemical potential in reconstituted cytochrome c oxidase vesicles and in vesicles exhibiting a potassium ion diffusion potential.

Authors:  T D Madden; T E Redelmeier
Journal:  J Bioenerg Biomembr       Date:  1994-04       Impact factor: 2.945

4.  The inhibition of a membrane-bound enzyme as a model for anaesthetic action and drug toxicity.

Authors:  B B Hasinoff; J P Davey
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

5.  The iron(III) and copper(II) complexes of adriamycin promote the hydrolysis of the cardioprotective agent ICRF-187 ((+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane).

Authors:  B B Hasinoff
Journal:  Agents Actions       Date:  1990-03

6.  The interaction of the cardioprotective agent ICRF-187 [+)-1,2-bis(3,5-dioxopiperazinyl-1-yL)propane); its hydrolysis product (ICRF-198); and other chelating agents with the Fe(III) and Cu(II) complexes of adriamycin.

Authors:  B B Hasinoff
Journal:  Agents Actions       Date:  1989-03

7.  The removal of metal ions from transferrin, ferritin and ceruloplasmin by the cardioprotective agent ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane] and its hydrolysis product ADR-925.

Authors:  B B Hasinoff; S V Kala
Journal:  Agents Actions       Date:  1993-05

8.  Inhibition and inactivation of NADH-cytochrome c reductase activity of bovine heart submitochondrial particles by the iron(III)-adriamycin complex.

Authors:  B B Hasinoff
Journal:  Biochem J       Date:  1990-02-01       Impact factor: 3.857

9.  Comparison of the protective effects of desferrioxamine and ICRF-187 against doxorubicin-induced toxicity in spontaneously hypertensive rats.

Authors:  E H Herman; J Zhang; V J Ferrans
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

10.  The iron(III)-adriamycin complex inhibits cytochrome c oxidase before its inactivation.

Authors:  B B Hasinoff; J P Davey
Journal:  Biochem J       Date:  1988-03-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.